Revilico Inc.

Revilico is an end-to-end drug discovery platform that bridges computational modeling and experimental validation. By combining industry leading AI, physics-driven software, and a robust wet lab marketplace, we streamline the entire drug development pipeline. Our platform integrates generative chemistry, molecular dynamics, and deep learning with seamless access to experimental validation. This fusion enables researchers to move from theoretical designs to wet lab results with unmatched speed and efficiency, drastically reducing the time and cost of pharmaceutical development. Revilico empowers scientists to identify meaningful disease targets, screen billions of molecules for ideal safety and efficacy, identify and optimize promising therapeutic candidates, design and optimize lead compounds, and bring transformative therapies to market faster than ever before.